30results about How to "Stable curative effect" patented technology

The invention discloses a formula of a traditional Chinese medicine for treating diabetic nephropathy. The formula is characterized by involving the following raw materials by weight: 6 parts of astragalus roots, 3 parts of Pseudostellaria heterophylla, 2 parts of angelica, 2 parts of radix rehmanniae, 2 parts of cornus officinalis, 2 parts of Salvia miltiorrhiza, 3 parts of raw coix seeds, 2 parts of earthworm, 2 parts of Poria, and 2 parts of rhizoma alismatis. Directed at qi-yin deficiency, i.e. the traditional Chinese medicinal core pathogenesis of diabetic nephropathy, the formula has the efficacy of supplementing Qi and nourishing Yin, dispersing blood stasis and promoting dieresis, and is suitable for different-stage diabetic nephropathy with the main manifestations of soreness and weakness of waist and knees, weakness all over the body, edema, foaming urine, nausea, skin pruritus, limb numbness or acroanesthesia (or chilling), dark red tongue, thin or greasy tongue coat, thin pulse or rapid pulse and the like. The formula involves simple medicines and can achieve a special effect. Previous long-term clinical practice and scientific research prove that the formula can significantly reduce the urinary protein excretion rate, delay the renal function progress, effectively improve glucolipid metabolism, effectively control blood pressure, improve the quality of life of patients, and greatly decrease kidney disease end point events, and has the advantages of stable long-term effect and good safety.

The invention relates to a method for extracting total triterpenoids and monomer ilicin A of enriched Hainan holly leaf. The method is characterized by comprising the following extraction steps that raw materials of Hainan holly leaf is subjected to reflux extraction by 50 percent to 95 percent of ethanol, liquid supernatant and a precipitation part are obtained after the extraction liquid is concentrated and centrifuged, the precipitation part is subjected to mixed suspension by 30 percent to 40 percent of ethanol, then, petroleum ether is used for extraction, the lower layer solution is subjected to pressure reduction, concentration and drying to obtain total triterpenoids; in addition, the ethanol extraction liquid is subjected to pressure reduction, recovery and evaporation to dryness, water is used for dissolving, acid is added for hydrolysis, organic solvents are extracted, the recovery to dryness, the silicagel column coating and the sherwood oil-ethyl acetate gradient elution are carried out, eluant is collected, elution solvents are recovered through pressure reduction, and the monomer ilicin A is obtained. According to an extraction enriching method, the total triterpenoids content of the obtained product exceeds 50 percent, the purity of the monomer ilicin A is high, meanwhile, the repeatability and the stability of the method are good, the transfer rate of effective ingredients of the raw material is high, the cost is low, the operation is simple and convenient, and the method is suitable for industrial production. Meanwhile, the invention also relates to application of the total triterpenoids and the monomer ilicin A of Hainan holly leaf in the cardiovascular disease treating aspect, in particular to the atherosclerosis aspect, and the potential development value is realized.

The invention discloses an oral administration pharmaceutical composition for treating nerve root type cervical vertebra diseases, which is prepared from astragalus root, pilose asiabell root, root of red rooted saliva, kudzu vine root, root of herbaceous peony, prepared Sichuan aconite root, Ligusticum wallichii, epimeddium, cassia twig, Chinese angelica root, large-leaf gentian root, pyrola, cortex acanthopanacis, spatholobus stem, wood louse, fleece-flower root, dahurian angelica root, futokadsura stem, Clematis chinensis, asaryl, flatsedge tuber and earthworm. The medicament should be decocted in water for the oral dose.

The invention relates to a traditional Chinese medicine composition for treating postpartum urinary retention. The traditional Chinese medicine composition is prepared from the bulk drugs in parts by weight: 13-17 parts of astragalus membranaceus, 13-17 parts of codonopsis pilosula, 8-12 parts of atractylodes rhizome, 8-12 parts of poria cocos, 8-12 parts of grifola, 8-12 parts of rhizome alismatis, 8-12 parts of semen plantaginis, 8-12 parts of radix bupleuri, 8-12 parts of medlar, 8-12 parts of cassia twig, 8-12 parts of angelica sinensis, 8-12 parts of platycodon grandiflorum, 3-7 parts of cimicifugae foetidae and 3-7 parts of liquorice. The traditional Chinese medicine composition has the advantages of stable curative effect and no side effect.

The invention discloses a traditional Chinese medicine for treating hypertension. The traditional Chinese medicine is prepared by decocting the following components in certain proportion: rhizoma atractylodis macrocephalae, gastrodia elata, poria cocos, uncaria, rhizoma alismatis, chrysanthemum flower, corn stigma, nacre mother of pearl, lumbricus, radix glycyrrhizae and water. The traditional Chinese medicine disclosed by the invention is absorbed by body after being drunk to achieve a treatment effect, is suitable for various crowds and capable of effectively clearing blood vessel garbage to purify a blood vessel channel. Meanwhile, the traditional Chinese medicines with effects of nourishing the blood vessels can be used for protecting or regulating the elasticity of the blood vessels. The traditional Chinese medicine is stable in curative effect, so that the blood pressure does not immediately returns to high pressure level once the traditional Chinese medicine is stopped.

The composition of Chinese medicine for curing diabetes is formed from (by weight ratio) scutellaria root 3-10, phellodendron bark 3-12, astragalus root 8-12, red ginseng 5-10, dried/fresh rehmannia root 10-18 and poria 7-14. Said invented Chinese medicine can completely regulate magnesium of human body, balance internal yin and yang, improve qi and blood distribance, recover functions of internal organs, strengthen kidney and fortify spleen and can promote islet cell to normally secrete insulin so as to obtain the goal of curing diabetes.

The invention provides a capsule for treating peptic ulcer and helicobacter pyloridis. The capsule is characterized by comprising the following medicines by weight: 20g of rhizoma atractylodis macrocephalae, 12g of endothelium corneum gigeriae galli, 2.4g of dried alum, 12g of concha arcae, 16g of cuttlebone, 12g of elephant hide, 4g of radix notoginseng, 8g of radix angelicae, 16g of bletilla striata, 12g of rhizoma corydalis, 9.6g of bulb of fritillary, 12g of dendrobe, 4.8g of liquorice and 4g of fructus amomi. The compound traditional Chinese medicine has a relatively good curative effect on helicobacter pylori infection, can play a significant HP role, and simultaneously can treat HP infection-related diseases through a correct traditional Chinese medicine syndrome differentiation formula.

The invention relates to a drug preparation technology, and aims to provide an application method of radix paeoniae alba and herba dendrobii officinalis to preparation of an antihypertensive drug. Theapplication method comprises the following steps: grinding radix paeoniae alba into powder, performing alcohol extraction on the radix paeoniae alba powder, extracting residual water left after the alcohol extraction, and combining concentrated extracting solutions; grinding the caulis dendrobii officinalis into powder, adding the caulis dendrobii officinalis powder into the combined extracting solution, and adding accessories to obtain the antihypertensive drug. A combination of an extract prepared by alcohol extraction and water extraction of the radix paeoniae alba and the caulis dendrobiiofficinalis powder has an outstanding curative effect on hypertension, and has an antihypertensive effect which can exceed a western medicine of irbesartan. Compared with conventional water extraction, the alcohol-water extraction method for the radix paeoniae alba has the advantages that component loss is reduced, the effectiveness is improved, complete utilization of oral radix paeoniae alba byhuman body is facilitated, and the curative effect is improved. Compared with most western antihypertensive drugs, the antihypertensive drug has a selective regulating effect on people with high blood pressure without influencing normal blood pressure: the antihypertensive drug can lower high blood pressure, but do not lower normal blood pressure or lower the high blood pressure below normal level.

The invention discloses a vulnerary hemostatic and a preparation process thereof. The vulnerary hemostatic comprises the raw Chinese medicinal herbs as main medicaments by weight: 20-40 parts of baeckea frutescens, 10-30 parts of big-leaf beautyberry leaf, 10- 30 parts of ageratum conyzoides, 10-30 parts of hairyvein agrimony, 10-30 parts of teucrium viscidum, and 10-30 parts of herba cirsii japonica, which are mainly used for stopping bleeding and relieving pain; straw, red psychotria leaf, false China tree and lemon-scented gum leaf capable of diminishing inflammation and promoting tissue regeneration can be used as auxiliary medicaments; adhatoda ventricosa, common gendarussa herb and glechoma biondiana with the functions of removing blood stasis, promoting tissue regeneration and promoting blood circulation to remove meridian obstruction are used as assistant; and through reasonable combination, the pharmacological functions of stopping bleeding, relieving pain, diminishing inflammation, removing blood stasis, promoting tissue regeneration and promoting blood circulation to remove meridian obstruction are realized, and the aims of quickly treating wound and stopping bleeding are fulfilled. According to the vulnerary hemostatic preparation process, the finished product is prepared by the processes of crushing, sieving, drying, stirring and the like; and the original effects of the medicaments are preserved, the properties of the medicaments are not affected because the medicaments are not chemically processed, and the obtained finished product has a stable treatment effect. The vulnerary hemostatic has the characteristics of high hemostatic speed, low cost, good effects of diminishing inflammation, relieving pain and promoting tissue regeneration, no toxic or side effect, convenience in use, convenience in collection of raw medicinal herbs and easiness for popularization and application.

The present invention discloses a traditional Chinese medicine composition for treating chronic enteritis by internal administration, which pertains to the field of traditional Chinese medicine. The parts by weight of the pharmaceutical raw materials to make the active ingredients of the traditional Chinese medicine composition for treating chronic enteritis by internal administration are: 15 parts of pilose Asiabell root, 10 parts of stir-fried largehead atractylodes rhizome, 15 parts of roasted membranous milkvetch root, 30 parts of halloysit, 24 parts of stir-fried coix seed, 10 parts of divaricate saposhnikovia root, 10 parts of roasted costustoot, 6 parts of roasted largetrifoliolious bugbane rhizome, 3 parts of catechu, 15 parts of yanhusuo, 15 parts of stir-fried dark plum fruit, 10 parts of Indian buead and 3 parts of golden thread. The water is used for boiling or the medicines are ground into the powder, and then the present invention is taken after mixing with the warm water. The medicine composition of the present invention can have the synergistic effect of the efficacy and achieve the effects of tonifying spleen, coordinating intestines, astringing and stopping diarrhea. The traditional Chinese medicine composition for treating chronic enteritis by internal administration achieves the significant effect, stable efficacy and no toxicity or side effects in the treatment of chronic enteritis. The clinical verification of about 100 cases proves that the effective rate can achieve 100 percent.

The invention relates to a Chinese medicament for treating bone fractures, and belongs to the technical field of Chinese medicaments. The Chinese medicament for treating the bone fractures comprises the following components in part by weight: 80 to 100 parts of tall gastrodia tuber, 50 to 80 parts of radix pseudo-ginseng, 50 to 100 parts of safflower, 20 to 30 parts of Chinese flowering quince, 80 to 100 parts of Chinese angelica, 30 to 50 parts of incised notopterygium rhizome, 30 to 50 parts of twotooth achyranthes root, 20 to 30 parts of scorpion, 30 to 50 parts of diverse wormwood herb and 20 to 30 parts of yanhusuo. Clinical experiments for many years prove that the Chinese medicament for treating the bone fractures has the good effect on the treatment of protrusion of lumbar vertebral disc, hyperosteogeny, scapulohumeral periarthritis, cervical spondylosis, strain of lumbar muscles and the like, and has advantages of stable curative effect, relapse prevention and no toxic or side effect.

The invention discloses blood stasis-removing powder for treating esophageal cancer. The blood stasis-removing powder is mainly prepared from the following active pharmaceutical ingredients in parts by weight: 5-10 parts of toad skin, 20-40 parts of kudzuvine root, 3-5 parts of borax, 3-6 parts of madagascar periwinkle herb, 10-20 parts of java brucea fruits, 9-16 parts of nidus vespae, 3-6 parts of vietnamese sophora root, 2-4 parts of realgar, 5-10 parts of blackberrykiky rhizome, 6-9 parts of natural indigo, 4-9 parts of swim bladder of croaker and an appropriate amount of fresh dog bile. The blood stasis-removing powder provided by the invention is safe in administration, has no side effects, has the effects of reducing swelling, relieving sore throat and clearing away heat and toxic materials, and has significant clinical effects against esophageal cancer.

The invention relates to a traditional Chinese medicine composition for treating seborrheic dermatitis. The traditional Chinese medicine composition is prepared from the following medicine raw materials in parts by weight: 22-28 parts of radix polygoni multiflori, 22-28 parts of flos chrysanthemi indici, 13-17 parts of tribulus terrestris, 13-17 parts of cortex dictamni, 13-17 parts of belvedere fruit, 8-12 parts of radix paeoniae alba, 8-12 parts of radix paeoniae rubra, 8-12 parts of cortex moutan radicis, 8-12 parts of radix scrophulariae, 22-28 parts of gypsum fibrosum, 22-28 parts of oldenlandia diffusa, 8-12 parts of radix scutellariae, 13-17 parts of polygonum cuspidatum, 8-12 parts of liquorice, 8-12 parts of radix bupleuri, 8-12 parts of fructus aurantii immaturus and 3-7 parts of rheum officinale. The traditional Chinese medicine composition for treating seborrheic dermatitis has the advantages of stable curative effect and no side effect.

The invention provides a divalproex sodium sustained-release agent composition. The composition comprises divalproex sodium accounting for 60 to 80% of the total weight of the composition, a sustained-release material accounting for 10 to 39% of the total weight of the composition and a lubricating agent accounting for 1 to 10% of the total weight of the composition, wherein the sustained-release material is one selected from the group consisting of stearic acid, hydrogenated castor oil, glyceryl behenate, palm wax and mixtures of the above-mentioned substances, and the lubricating agent is one selected from the group consisting of magnesium stearate, silica, talcum powder and mixtures of the above-mentioned substances. The invention also provides a preparation method for the divalproex sodium sustained-release agent composition. The composition is simple in formula, needs no accessory materials like a binder and a disintegrating agent essential in conventional preparation production and provides a sustained-release preparation with stable curative effect, long-lasting action and convenience in administration for clinical practice. Compared with the prior art, the invention has the following advantages: the preparation method for a divalproex sodium sustained-release tablet is simple and effective and can be easily scaled-up.

The invention discloses a pharmaceutical composition for treating gastroenteritis and a preparation method, a preparation and an application thereof. The pharmaceutical composition comprises the following raw materials in parts by weight: 20-150 parts of Costustoot, 20-100 parts of wrinkled giant hyssop, and 10-80 parts of Corydalis saxicola. The pharmaceutical composition is obtained by pre-treatment, extraction and post-treatment. The tablets, powder, capsules, a particulate agent and pill prepared by the pharmaceutically acceptable auxiliary materials can be added in the pharmaceutical composition for treating gastroenteritis, which is the application of the pharmaceutical composition for treating gastroenteritis. The raw materials are combined for synergism, and have the functions for clearing heat and removing dampness as well as rectifying qi and relieving pain, and the pharmaceutical composition is used for treating gastroenteritis.

The invention discloses an application of botulinum toxin A to resistance of depression, and belongs to the field of medical technology. The botulinum toxin A is used for preparing an antidepressant product. The botulinum toxin A can be used for effectively controlling and treating depression, and compared with chemically synthesized medicaments, the effects of the technical scheme are smaller andcurative effects are stable. The technical scheme has simple technology and few operation steps, and is suitable for production of industrialization scale.

The invention relates to a traditional Chinese medicine composition for treating acute urinary tract infection. The traditional Chinese medicine composition is prepared from the following raw pharmaceutical materials: oldenlandia diffusa, herba leonuri, herba plantaginis, common knotgrass, raw liquorice, cogon grass rhizome, raw milkvetch root, fried atractylodes macrocephala, ledebouriella root, malva seed, anemarrhena rhizome and phellodendron bark. The invention further provides application of the traditional Chinese medicine composition. The traditional Chinese medicine composition disclosed by the invention has the effects of clearing away heat and toxic materials and relieving stranguria by diuresis through combining monarch, ministerial, adjuvant and guide drugs. Shown by clinical trials, the traditional Chinese medicine composition has a remarkable treatment effect.

The invention is applicable to the technical field of medical materials and provides an anti-fatigue compound preparation and a preparation method thereof. The anti-fatigue compound preparation comprises raw materials in parts by weight as follows: 30-65 parts of herba cistanche, 5-25 parts of galangal, 20-50 parts of Chinese dates, 20-50 parts of acanthopanax roots, 20-50 parts of epimedium herb,5-25 parts of notoginseng buds and 55-80 parts of black tea. The herba cistanche, the galangal, the Chinese dates, the acanthopanax roots, the epimedium herb, notoginseng buds and the black tea are matched, all medicinal materials cooperate to take effect jointly to have the anti-fatigue function and have the anti-fatigue effect on wide people. Experiments prove that the anti-fatigue compound preparation has significant anti-fatigue effect and stable curative effects, has an immunity enhancing effect, is reasonable in compatibility of all medicines, has no side effects and is suitable for long-term taking.

The invention provides medicinal herbal paste with conditioning functions of nourishing kidney and lung, tonifying spleen and eliminating phlegm as well as a preparation technology of the herbal paste. The self-made herbal paste is obtained by the center for preventive treatment of diseases of the department after a large quantity of clinical practice, the trouble that a patient decocts traditional Chinese medicine decoction by oneself is omitted, and the herbal paste is stable in curative effect and efficacy, easy to store and convenient to carry, tastes good, can be taken for a long time, has few side effects compared with Western medicine and has the unique advantage in the aspect of conditioning of bronchial asthma and chronic respiratory diseases.

The invention relates to a compound crystal form, a preparation method and use thereof and a pharmaceutical composition and particularly relates to a crystal form of a gemcitabine predrug, a preparation method and use of the crystal form and an anti-cancer pharmaceutical composition containing the crystal form of the gemcitabine predrug. The crystal form is a crystal form of the gemcitabine predrug represented by a formula I (shown in the description), and an X-ray powder diffraction pattern of the crystal form has a characteristic peak when a diffraction angle 2theta is 6.30+/-0.2 degrees, 8.88+/-0.2 degrees, 9.15+/-0.2 degrees, 12.52+/-0.2 degrees, 14.85+/-0.2 degrees, 15.86+/-0.2 degrees, 17.24+/-0.2 degrees, 17.66+/-0.2 degrees, 18.26+/-0.2 degrees, 20.37+/-0.2 degrees, 21.74+/-0.2 degrees, 22.14+/-0.2 degrees and the like. The invention further discloses the preparation method of the crystal form of the gemcitabine predrug, use of the crystal form for preparation of anti-cancer drugs and the anti-cancer pharmaceutical composition containing the crystal form of the gemcitabine predrug.

The invention discloses a capsule for treating lumbar disc herniation. The capsule is prepared from the following ingredients in mass: 2 to 4g of asarum, 8 to 12g of earthworm, 9 to 13g of pangolin, 4 to 6g of woodlouse, 1 to 3g of pearl powder and 1 to 3g of herba epimedii. Each kind of traditional Chinese medicine is screened, cleaned, dried, ground and sieved, and is then respectively weighed according to the mass; the materials are mixed, are uniformly stirred and are charged into a hollow capsule according to the quantity; and the capsule can be prepared. The capsule provided by the invention belongs to medicine for treating lumbar disc herniation through oral administration; the medicine is pure natural traditional Chinese medicine; the taking is convenient; the curative effect is stable and thorough; no toxic or side effect exists; the surgical pain is avoided; the rest in bed is not needed; and the lumbar disc herniation can be thoroughly cured.

The invention belongs to the field of medicines, and particularly relates to a medicine composition for treating diarrhea as well as a preparation method and application thereof. The technical problem to be solved by the invention is to provide the new medicine composition. The new medicine composition comprises the following medicinal raw materials in parts by weight; 1-3 parts of ephedra, 1-4 parts of radix peucedani and 2.5-4.5 parts of semen plantaginis. The purpose of treating or improving diarrhea can be realized by the method. For the convenience of application and the simpleness and convenience of preparations, the medicine composition is prepared into decoction for use by an inventor. The medicine composition is used for clearing damp and stopping diarrhea, is suitable for treatment of diarrhea of children aged 0 to 12 years and can also be taken by adults. The medicine composition can be used for treating various types of diarrheas and is particularly suitable for gastrointestinal type cold and simple diarrhea and chronic diarrhea of children; and more than 10 years of clinical application observation proves that more than 300 of diarrhea patents are treated, and the recovery rate is above 95%. The medicine composition can also be used for treating cold and relieving a cough, treats more than 200 of patients suffering from cold and cold and has the recovery rate of above 85%.

The invention relates to a traditional Chinese medicinal pillow for treating children rhinitis. The traditional Chinese medicinal pillow comprises a pillow core, wherein the pillow core is filled withthe following traditional Chinese medicinal granules in parts by weight: 100 to 150 parts of folium artemisiae argyi, 20 to 30 parts of alpine yarrow herb, 20 to 25 parts of herba taraxaci, 25 to 30parts of honey-processed herba ephedrae, 10 to 15 parts of thin evodia, 20 to 25 parts of cortex cinnamomi, 10 to 15 parts of greater celandine herb and 5 to 10 parts of herba menthae. The traditionalChinese medicinal pillow is prepared by drying traditional Chinese medicinal crude drugs, crushing into granules with rice grain sizes, feeding into a cloth bag and putting into the pillow core. Thetraditional Chinese medicinal pillow for treating children rhinitis, disclosed by the invention, has the advantages that by using a physical therapy, medicines can directly enter nasal mucosa, so thatanti-inflammation and sterilization can be realized; in addition, the effect is good and no toxic or side effects are found.

The invention discloses a medicinal composition for treating osteoporosis. The medicinal composition is prepared from the following raw material components in parts by weight: 5 to 25 parts of American ginseng, 8 to 25 parts of lily bulb, 5 to 20 parts of Smilacina japonica, 3 to 10 parts of donkey-hide gelatin, 10 to 25 parts of Chinese yam and 5 to 15 parts of stem of champion bauhinia. The herbal raw materials are used as medicine, and a preparation has efficacies for dredging the channels, regulating the body and mind, tranquilizing and allaying excitement, astringing, repairing bone lesion and strengthening bones and muscles, so that the osteoporosis can be fundamentally treated, the body can be regulated, and the body condition can be improved.

The invention discloses an application of a kidney-tonifying and brain-benefiting preparation in preparation of a medicine for treating infantile cerebral palsy. The kidney-tonifying and brain-benefiting preparation comprises the following components in parts by weight: 30-80 parts of red ginseng, 4-12 parts of cornu cervi pantotrichum, 30-80 parts of fried spina date seeds; 80-120 parts of prepared rehmannia roots, 30-80 parts of poria cocos, 25-55 parts of radix scrophulariae, 30-80 parts of honey-stir-baked polygala roots, 30-80 parts of radix ophiopogonis, 25-55 parts of schisandra chinensis, 30-80 parts of angelica sinensis, 25-55 parts of Sichuan lovage rhizomes, 25-55 parts of radix achyranthis bidentatae, 30-80 parts of fried Chinese yams, 25-55 parts of salt-processed fructus psoraleae, 25-55 parts of Chinese wolfberry fruits and 8-18 parts of cinnabar. The kidney-tonifying and brain-benefiting preparation has an exact effect of treating infantile cerebral palsy, can relieve pains of children patients, promotes liver, kidney, spleen and stomach function repair and function recovery of the children patients, and promotes brain development and recovery of the children patients.

The invention relates to an externally-applied ointment for treating chilblains and a preparation method thereof. The externally-applied ointment is prepared from, by weight, 18-22 parts of radix codonopsis, 18-22 parts of pine needles, 18-22 parts of radix cynanchi paniculati, 18-22 parts of pericarpium zanthoxyli, 11-13 parts of radix ginseng rubra, 11-13 parts of herba cistanche, 11-13 parts of semen allii tuberose, 11-13 parts of mulberry twigs, 8-10 parts of radix aconiti carmichaeli, 8-10 parts of cornus officinalis, 8-10 parts of radix polygoni multiflori, 8-10 parts of radix dipsaci, 8-10 parts of cassia twigs, 4-6 parts of herba epimedii, 4-6 parts of radix achyranthis bidentatae, 4-6 parts of cortex eucommiae, 4-6 parts of rheum officinale and 4-6 parts of folium perillae. The externally-applied ointment has the advantages of being stable in treatment effect and free of side effects; it is clinically verified that the effective rate is 100% when the externally-applied ointment is used for treating the chilblains.

The invention relates to a drug for treating hepatitis B, which is prepared by Chinese herbal medicines. The drug is characterized in that the drug comprises the main drugs with the following weights: 80 to 160g of Mongolian dandelion herb, 100 to 200g of humifuse euphorbia herb, 80 to 160g of cudrania cochinchinensis, 80 to 160g of sun euphorbia herb, 90 to 180g of common knotgrass herb and 130 to 240g of root of hedge glorybind; and the adjuvant with the following weight: 90 to 170g of white mulberry root-bark. The whole formula has perfect compatibility, powerful drug efficacy and orderly sequence, which can hit the disease mechanism and fully reflect the treatment principles of clearing heat, removing toxin, activating blood circulation, dredging channels, promoting diuresis, removing edema, resolving phlegm, abating jaundice and invigorating essential qi.

The invention relates to Anderson's disease and a therapeutic drug thereof, belongs to the technical field of medicine, and aims to solve the problem of difficulty in Anderson's disease treatment. According to analysis, the Anderson's disease is caused by congenital deficiency, liver-kidney yin deficiency and phlegm-caused meridian obstruction, and patients shall take the therapeutic drug, which comprises traditional Chinese medicinal herbs with effects of clearing liver, promoting blood circulation, tonifying spleen and qi, dispelling the wind, reducing phlegm, and activating channels and collaterals, to treat the Anderson's disease. The therapeutic drug comprises, by weight, 15 parts of radix sileris, 15 parts of sealwort, 15 parts of epimedium, 15 parts of turtle shells, 15 parts of the root bark of the peony tree, 15 parts of dried rehmannia roots, 15 parts of cistanche, 15 parts of lalang grass rhizomes, 15 parts of safflowers, 15 parts of houttuynia cordata, 15 parts of dried tangerine or orange peels, 10 parts of ginger, 15 parts of chrysanthemums, 10 parts of fried semen strychni and 8 parts of liquorice. The therapeutic drug has the advantages that stable curative effect is achieved, a positive theoretical solution for treating the Anderson's disease by traditional Chinese medicine is put forward, and the patients can rebuild their confident lives.

The invention discloses a quercetin sustained release tablet which is prepared from quercetin, a sustained release material and other auxiliary materials. The invention also discloses a preparing method of the quercetin sustained release tablet. With the sustained release tablet, the administration times and amount are reduced, stable and lasting release of the medicine is achieved, and the safety and effectiveness of the medicine are improved.

The invention relates to a traditional Chinese medicine composition for treatment of prostatic hyperplasia, belonging to the field of traditional Chinese medicine. The traditional Chinese medicine composition is characterized by being prepared from the following traditional Chinese medicine raw materials: 4-8 parts of Cimicifuga, 20-40 parts of medicinal cyathula root, 10-20 parts of herba epimedii, 15-25 parts of dodder, 15-25 parts of Eclipta alba, 4-8 parts of leech, 4-8 parts of ground beeltle, 2-5 parts of pangolin, 20-40 parts of talc, 20-40 parts of Lygodium japonicum and 4-8 parts of amber. The traditional Chinese medicine composition has the functions of treating both symptoms and root causes, and combining dredging and tonifying effects, has remarkable treatment effect on prostatic hyperplasia, and has steady curative effect and no toxic or side effect.